Clinical Trial Update: Systemic Absorption of Lidocaine After Hematoma Block [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating systemic absorption of lidocaine after a hematoma block was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematoma
• Radius Fracture Distal

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Radius Fracture Distal, Hematoma | Phase 4 | Status: WITHDRAWN